Anti-Cancer Agents in Medicinal Chemistry- Anti-Cancer Agents)

Editorial [Hot Topic : Targeting Focal Ahhesion Kinase in Cancer-Part I (Guest Editor: Vita M. Golubovskaya)]
pp. 713-713(1)
Author: Golubovskaya, Vita

Targeting Focal Adhesion Kinase in Neuroblastoma
pp. 714-721(8)
Authors: Gillory, Lauren; A. Beierle, Elizabeth

Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
pp. 722-734(13)
Authors: Bullard Dunn, Kelli; Heffler, Melissa; M. Golubovskaya, Vita

Focal Adhesion Kinase as a Cancer Therapy Target
pp. 735-741(7)
Author: M. Golubovskaya, Vita

FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer
pp. 742-746(5)
Authors: A. Ucar, Deniz; N. Hochwald, Steven

Focal Adhesion Kinase as a Therapeutic Target of Bortezomib
pp. 747-752(6)
Authors: Ko, Bor-Sheng; Chang, Tzu-Ching; Liou, Jun-Yang

Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
pp. 753-768(16)
Authors: Mas-Moruno, Carlos; Rechenmacher, Florian; Kessler, Horst

Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines
pp. 769-776(8)
Authors: M. Cazal, Cristiane; Choosang, Kantima; Gisele P. Severino, Vanessa; S. Soares, Marcio; Lucio F. Sarria, Andre; B. Fernandes, Joao; Fatima G.F. Silva, Maria; Cezar Vieira, Paulo; Pakkong, Pannee; M. Almeida, Gabriela; Helena Vasconcelos, M.; S.J. Nascimento, Maria; M.M. Pinto, Madalena